FI91064B - Menetelmä terapeuttisesti vaikuttavien 3-(N-asyylietyyli-aminoalkyyli)-kromaanien ja -1,4-dioksaanien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti vaikuttavien 3-(N-asyylietyyli-aminoalkyyli)-kromaanien ja -1,4-dioksaanien valmistamiseksi

Info

Publication number
FI91064B
FI91064B FI872807A FI872807A FI91064B FI 91064 B FI91064 B FI 91064B FI 872807 A FI872807 A FI 872807A FI 872807 A FI872807 A FI 872807A FI 91064 B FI91064 B FI 91064B
Authority
FI
Finland
Prior art keywords
denotes
alkylcarbamyl
oxygen atom
optionally
dilower
Prior art date
Application number
FI872807A
Other languages
English (en)
Swedish (sv)
Other versions
FI91064C (fi
FI872807A7 (fi
FI872807A0 (fi
Inventor
Wolfgang Froestl
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI872807A0 publication Critical patent/FI872807A0/fi
Publication of FI872807A7 publication Critical patent/FI872807A7/fi
Application granted granted Critical
Publication of FI91064B publication Critical patent/FI91064B/fi
Publication of FI91064C publication Critical patent/FI91064C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI872807A 1986-06-26 1987-06-24 Menetelmä terapeuttisesti vaikuttavien 3-(N-asyylietyyli-aminoalkyyli)-kromaanien ja -1,4-dioksaanien valmistamiseksi FI91064C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH258886 1986-06-26
CH258886 1986-06-26

Publications (4)

Publication Number Publication Date
FI872807A0 FI872807A0 (fi) 1987-06-24
FI872807A7 FI872807A7 (fi) 1987-12-27
FI91064B true FI91064B (fi) 1994-01-31
FI91064C FI91064C (fi) 1994-05-10

Family

ID=4237161

Family Applications (1)

Application Number Title Priority Date Filing Date
FI872807A FI91064C (fi) 1986-06-26 1987-06-24 Menetelmä terapeuttisesti vaikuttavien 3-(N-asyylietyyli-aminoalkyyli)-kromaanien ja -1,4-dioksaanien valmistamiseksi

Country Status (16)

Country Link
EP (1) EP0252005B1 (fi)
JP (1) JPH0699420B2 (fi)
AT (1) ATE65084T1 (fi)
AU (1) AU617988B2 (fi)
CA (1) CA1322553C (fi)
CY (1) CY1783A (fi)
DD (1) DD279674A5 (fi)
DE (1) DE3771280D1 (fi)
DK (1) DK325587A (fi)
ES (1) ES2044970T3 (fi)
FI (1) FI91064C (fi)
GR (1) GR3002308T3 (fi)
HK (1) HK134994A (fi)
HU (1) HU207061B (fi)
IE (1) IE59881B1 (fi)
PT (1) PT85157B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322361A3 (de) * 1987-12-23 1990-01-24 Ciba-Geigy Ag Weitere hydrierte 1-Benzooxacycloalkylpyridincarbonsäureverbindungen
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
EP0389425B1 (de) * 1989-03-22 1995-04-26 Ciba-Geigy Ag Neue Benzothiopyranylamine
US5189179A (en) * 1990-08-29 1993-02-23 Merrell Dow Pharmaceuticals Inc. Serotonin 5ht1a agonists
US5212170A (en) * 1991-06-21 1993-05-18 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5221745A (en) * 1991-06-21 1993-06-22 American Home Products Corp. Psychotropic piperidinylmethyl benzodioxans
US5182292A (en) * 1991-06-21 1993-01-26 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5240943A (en) * 1991-12-19 1993-08-31 G. D. Searle & Co. Benzopyran class iii antiarrhythmic agents
FR2694005B1 (fr) * 1992-07-21 1994-08-26 Adir Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
JP3546657B2 (ja) * 1997-08-29 2004-07-28 株式会社トヨトミ 給湯機の缶体構造
CN101090888A (zh) * 2004-12-20 2007-12-19 霍夫曼-拉罗奇有限公司 4－氨基哌啶衍生物
RU2714893C2 (ru) 2014-12-05 2020-02-20 Земмельвайс Юнивёрсити Арилалкиламиновые соединения для применения для профилактики или лечения рака

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1366479A (fr) * 1962-08-20 1964-07-10 Res Lab Dr C Janssen Nv Procédé de production de nouveaux dérivés de la pipéridine et de leurs sels
GB1520801A (en) * 1975-01-16 1978-08-09 Lafon Labor Benzodioxanyl and benzofuranylmethylamines
AU552050B2 (en) * 1981-05-26 1986-05-22 Smithkline Beckman Corporation N-substituted azeheterocyclic carboxylic acids and their esters
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
FR2524887A1 (fr) * 1982-04-08 1983-10-14 Bouchara Emile Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
DE3411993A1 (de) * 1984-03-31 1985-10-10 Bayer Ag, 5090 Leverkusen Substituierte benzopyrane, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimittel
JPH0816108B2 (ja) * 1986-02-21 1996-02-21 株式会社クラレ ３，４−ジヒドロ−２ｈ−ベンゾピラン誘導体及びその医薬用途

Also Published As

Publication number Publication date
ATE65084T1 (de) 1991-07-15
JPH0699420B2 (ja) 1994-12-07
DK325587A (da) 1987-12-27
HK134994A (en) 1994-12-09
DD279674A5 (de) 1990-06-13
JPS638382A (ja) 1988-01-14
HUT48622A (en) 1989-06-28
DE3771280D1 (de) 1991-08-14
HU207061B (en) 1993-03-01
AU617988B2 (en) 1991-12-12
FI91064C (fi) 1994-05-10
IE871694L (en) 1987-12-26
AU8125587A (en) 1989-05-18
CA1322553C (en) 1993-09-28
EP0252005B1 (de) 1991-07-10
CY1783A (en) 1995-10-20
PT85157A (en) 1987-07-01
PT85157B (pt) 1990-03-30
DK325587D0 (da) 1987-06-25
EP0252005A1 (de) 1988-01-07
ES2044970T3 (es) 1994-01-16
IE59881B1 (en) 1994-04-20
GR3002308T3 (en) 1992-12-30
FI872807A7 (fi) 1987-12-27
FI872807A0 (fi) 1987-06-24

Similar Documents

Publication Publication Date Title
FI872807A0 (fi) Menetelmä terapeuttisesti vaikuttavien 3-(N-asyylietyyli-aminoalkyyli)-kromaanien ja -1,4-dioksaanien valmistamiseksi
ATE10741T1 (de) Dibenzo(b,f)(1,4)oxazepin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE99685T1 (de) Oxadiazolylalkylpurin-derivate, ihre herstellung und ihre verwendung in pharmazeutischen mitteln.
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
PT80779A (fr) Procede pour la preparation de nouvelles 2-amino-oxazolines et de compositions pharmaceutiques les contenant
DE3576075D1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
IL63381A0 (en) 5-substituted 5,10-dihydro-11h-dibenzo(b,e)(1,4)diazepin-11-one derivatives,their preparation and pharmaceutical compositions containing them
NO174851C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktiv hydroksyalkylfuranylderivater
ATE115145T1 (de) Penem-derivate, ihre herstellung und verwendung.
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE139441T1 (de) Verwendung von 2-iminothiazolidin-4-onderivaten als neuartige arzneimittelwirkstoffe
NO872982D0 (no) Nye tetracykliske indolderivater.
ES2009209A6 (es) Procedimiento para la obtencion de dihidropiridinlactoles.
DE3767533D1 (de) D-nor-7-ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zubereitung und verwendung.
ES481936A2 (es) Mejoras introducidas en la patente principal: procedimiento para la obtencion de compuestos oxotio.
ES464773A1 (es) Procedimiento para la preparacion de 2,9-dioxatriciclo (4,3,1,03,7)decanos.
EP0344982A3 (en) Alpha-adrenergic receptor antagonists

Legal Events

Date Code Title Description
FG Patent granted

Owner name: NOVARTIS AG

BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed
MM Patent lapsed

Owner name: NOVARTIS AG